Haddad R - Search Results

1

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Docampo LCI, Haddad R, Rordorf T, Kiyota N, Tahara M, Lynch M, Jayaprakash V, Li L, Gillison ML. Ferris RL, et al. Among authors: haddad r. Oral Oncol. 2018 Jun;81:45-51. doi: 10.1016/j.oraloncology.2018.04.008. Epub 2018 Apr 17. Oral Oncol. 2018. PMID: 29884413 Free PMC article. Clinical Trial.

2

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Haddad R, et al. Cancer. 2003 Jan 15;97(2):412-8. doi: 10.1002/cncr.11063. Cancer. 2003. PMID: 12518365 Free article.

3

Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study.

Haddad R, Colevas AD, Krane JF, Cooper D, Glisson B, Amrein PC, Weeks L, Costello R, Posner M. Haddad R, et al. Oral Oncol. 2003 Oct;39(7):724-7. doi: 10.1016/s1368-8375(03)00097-6. Oral Oncol. 2003. PMID: 12907212 Clinical Trial.

4

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.

Haddad R, Wirth L, Costello R, Weeks L, Posner M. Haddad R, et al. Semin Oncol. 2003 Dec;30(6 Suppl 18):84-8. doi: 10.1053/j.seminoncol.2003.11.011. Semin Oncol. 2003. PMID: 14727246 Clinical Trial.

5

HER2 expression in salivary gland carcinomas: dependence on histological subtype.

Glisson B, Colevas AD, Haddad R, Krane J, El-Naggar A, Kies M, Costello R, Summey C, Arquette M, Langer C, Amrein PC, Posner M. Glisson B, et al. Among authors: haddad r. Clin Cancer Res. 2004 Feb 1;10(3):944-6. doi: 10.1158/1078-0432.ccr-03-0253. Clin Cancer Res. 2004. PMID: 14871971 Clinical Trial.

6

A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.

Haddad RI, Weinstein LJ, Wieczorek TJ, Bhattacharya N, Raftopoulos H, Oster MW, Zhang X, Latham VM Jr, Costello R, Faucher J, DeRosa C, Yule M, Miller LP, Loda M, Posner MR, Shapiro GI. Haddad RI, et al. Clin Cancer Res. 2004 Jul 15;10(14):4680-7. doi: 10.1158/1078-0432.CCR-04-0229. Clin Cancer Res. 2004. PMID: 15269140 Clinical Trial.

7

Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.

Gokhale AS, Haddad RI, Cavacini LA, Wirth L, Weeks L, Hallar M, Faucher J, Posner MR. Gokhale AS, et al. Among authors: haddad ri. Oral Oncol. 2005 Jan;41(1):70-6. doi: 10.1016/j.oraloncology.2004.06.005. Oral Oncol. 2005. PMID: 15598588

8

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, Sullivan C, Tishler RB. Posner MR, et al. Among authors: haddad ri. Semin Oncol. 2004 Dec;31(6):778-85. doi: 10.1053/j.seminoncol.2004.09.007. Semin Oncol. 2004. PMID: 15599855 Review.

9

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck.

Wirth LJ, Haddad RI, Lindeman NI, Zhao X, Lee JC, Joshi VA, Norris CM Jr, Posner MR. Wirth LJ, et al. Among authors: haddad ri. J Clin Oncol. 2005 Oct 1;23(28):6976-81. doi: 10.1200/JCO.2005.02.4182. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172459 Clinical Trial.

10

A 49-year-old male with locally advanced squamous cell carcinoma of the head and neck: the case for sequential chemoradiotherapy.

Haddad R, Norris CM, Posner MR. Haddad R, et al. Clin Adv Hematol Oncol. 2003 Jan;1(1):58-60; discussion 61-2. Clin Adv Hematol Oncol. 2003. PMID: 16227961 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,199 results

Search Page